Ricardo Silvera
Medical · South Miami, FLNPI 1255667192
Payments from drug & device makers
Across 171 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Redhill Biopharma Inc.$165
- Nevro Corp.$105
- Biohaven Pharmaceutical Holding Company Ltd.$93
- Averitas Pharma Inc.$88
- plus $434 from 14 others
What the payments were for
- Food & beverage$3,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 59 | $1,190 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 64 | $1,140 |
| Redhill Biopharma Inc. | 15 | $165 |
| Nevro Corp. | 4 | $105 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $93 |
| Averitas Pharma Inc. | 2 | $88 |
| Almatica Pharma LLC | 2 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Amgen | 2 | $46 |
| Boston Scientific | 2 | $44 |
| Valinor Pharma, LLC | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Biodelivery Sciences International, Inc. | 2 | $35 |
| AbbVie | 1 | $23 |
| Electronic Waveform Lab, Inc. | 1 | $21 |
| Nalu Medical, Inc. | 1 | $19 |
| Globus Medical | 1 | $17 |
| Medtronic | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Forte Bio-pharma LLC | 1 | $2 |
How this compares
$3,216 in reported general payments places this provider in the 75th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 126 | $52,806 |
| ZtlidoLidocaine | 70 | $42,780 |
| Diclofenac Sodium | 222 | $40,910 |
| LinzessLinaclotide | 21 | $11,924 |
| Lidocaine | 94 | $11,442 |
| Gabapentin | 579 | $6,283 |
| SymproicNaldemedine Tosylate | 12 | $5,291 |
| Naloxone Hcl | 47 | $3,367 |
| Tizanidine Hcl | 223 | $2,037 |
| Ondansetron Hcl | 11 | $1,833 |
| Methocarbamol | 61 | $1,631 |
| Baclofen | 165 | $1,588 |
| Lubiprostone | 15 | $767 |
| Celecoxib | 65 | $693 |
| Ondansetron OdtOndansetron | 25 | $652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $165 | $52,806126 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,190 | $42,78070 claims |
| AbbVieLinzess | $23 | $11,92421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,031 medical providers in Florida.
Other medical in South Miami
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.